LI-RADS 2018版对儿童肝细胞癌的诊断效能
本多机构回顾性研究纳入5家机构116例儿童(58例肝细胞癌,58例其他富血供肝脏病变),由3名放射科医师盲法独立应用LI-RADS 2018版标准。全队列中LR-4/5/TIV/M诊断恶性病变敏感度85%–88%、特异度54%–70%;在肝细胞癌高危亚组中敏感度58%–68%、特异度56%–63%。所有归为LR-TIV的病变均为肝细胞癌。
要点
- 儿童肝细胞癌中LI-RADS主要征象出现频率低:非环状动脉期高强化49%–62%、非周边廓清36%–59%、强化包膜28%–38%。
- 全队列LR-4/5/TIV/M诊断恶性病变敏感度85%–88%、特异度54%–70%。
- 高危亚组敏感度降至58%–68%、特异度56%–63%;归为LR-TIV的病变均为肝细胞癌。
关键影像表现/征象
- 儿童典型肝细胞癌中非环状动脉期高强化的出现频率为49%–62%(39例中19–24例)。
- 非周边廓清的出现频率为36%–59%(39例中14–23例)。
- 强化包膜的出现频率为28%–38%(39例中11–15例)。
诊断标准与关键数值
- 全队列中以LR-1、LR-2或LR-3对LR-4、LR-5、LR-TIV或LR-M的二分类预测恶性病变,3名医师的敏感度为85%(95%CI:76,94)至88%(95%CI:80,96)。
- 全队列中该二分类预测良性病变的特异度为54%(95%CI:40,68)至70%(95%CI:57,83)。
- 肝细胞癌高危亚组中敏感度为58%(95%CI:36,80)至68%(95%CI:48,89)。
- 肝细胞癌高危亚组中特异度为56%(95%CI:37,74)至63%(95%CI:45,81)。
- 所有归为LR-TIV的病变(n=10–13)均为肝细胞癌。
临床应用与阅片要点
- 儿童肝细胞癌中LI-RADS主要征象出现频率低,判读时需结合儿童人群特点。
- LR-TIV归类在儿童中均对应肝细胞癌,报告时需明确描述。
- 高危亚组敏感度与特异度均偏低,LI-RADS 2018版在儿童中的应用效能有限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The Liver Imaging Reporting and Data System (LI-RADS) has standardized the evaluation of adult but not pediatric hepatocellular carcinoma (HCC). Purpose To evaluate the performance of LI-RADS version 2018 for diagnosis of pediatric HCC. Materials and Methods This multi-institution retrospective study evaluated all available dynamic CT and/or MRI scans of pediatric (≤18 years) HCC from five institutions between July 2009 and April 2019. The control group included an equal number of other enhancing hepatic lesions. Blinded to final diagnosis, three radiologists independently applied LI-RADS version 2018 criteria. The reference standard was pathologic examination or more than 1 year follow-up. Sensitivity and specificity of LI-RADS were computed using a dichotomous classification of LR-1, LR-2, or LR-3 versus LR-4, LR-5, LR-TIV (tumor in vein), or LR-M (probably or definitely malignant but not HCC-specific) for predicting hepatic malignancy in the entire cohort and in patients at risk for HCC. Results The cohort consisted of 116 children: 58 with HCC (mean age, 12 years ± 5; 31 girls) and 58 with other enhancing hepatic masses (mean age, 12 years ± 5; 42 girls). Frequencies of major criteria in classic HCC for the three readers were as follows: nonrim arterial phase hyperenhancement, 49%-62% (19-24 of 39 patients); nonperipheral "washout," 36%-59% (14-23 of 39 patients); and enhancing "capsule," 28%-38% (11-15 of 39 patients). For the full cohort, the sensitivity of LR-4, LR-5, LR-TIV, or LR-M for malignancy among the three readers ranged from 85% (95% CI: 76, 94) to 88% (95% CI: 80, 96); specificity of LR-1, LR-2, or LR-3 for benignity ranged from 54% (95% CI: 40, 68) to 70% (95% CI: 57, 83). In the at-risk subgroup, sensitivity ranged from 58% (95% CI: 36, 80) to 68% (95% CI: 48, 89); specificity ranged from 56% (95% CI: 37, 74) to 63% (95% CI: 45, 81). All lesions categorized as LR-TIV (n = 10-13) were HCCs. Conclusion Liver Imaging Reporting and Data System version 2018 had moderate sensitivity but low specificity for the diagnosis of pediatric hepatocellular carcinoma (HCC), which had low frequencies of the major criteria used for adult HCC diagnosis. © RSNA, 2021 See also the editorial by Paltiel in this issue.
引用
- Khanna G, Chavhan GB, Schooler GR, et al. Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma. Radiology. 2021. PMID: 33620289. doi:10.1148/radiol.2021203559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。